tangeretin has been researched along with atorvastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bao, H; Li, Z; Zheng, N; Zhi, Y | 1 |
Gong, L; Jiang, Q; Li, W; Li, Y; Ni, D; Wang, S; Wang, W; Wu, W; Xu, X; Zhang, J; Zhang, T; Zhang, Y | 1 |
2 other study(ies) available for tangeretin and atorvastatin
Article | Year |
---|---|
Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Cell Line; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Female; Flavones; Humans; Kinetics; Ligands; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles; Neoplasms, Experimental; Oligopeptides; Particle Size | 2020 |
Ultra-high performance supercritical fluid chromatography-tandem mass spectrometry method for simultaneous determination of atorvastatin, 2-hydroxy atorvastatin, and tangeretin in rat plasma and its application to the pharmacokinetic study.
Topics: Animals; Atorvastatin; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Rats; Reproducibility of Results; Tandem Mass Spectrometry | 2022 |